Genzyme Corporation - SWOT Analysis

Datamonitor's Genzyme Corporation *SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Genzyme is a global biotechnology company focused on rare disorders, renal diseases, orthopedics, organ transplant, diagnostic and predictive testing, and cancer. The company primarily operates in the US and the UK. The company is headquartered in Cambridge, Massachusetts, and employs about 10,000 people. The company recorded revenues of $3,813.5 million during the financial year (FY) ended December 2007, an increase of 19.7% over 2006. The operating profit of the company was $653.8 million in FY2007, as compared to an operating loss of $190.5 million in 2006. The net profit was $480.1 million, as compared to a net loss of $16.7 million in 2006.

Scope of the Report

• Provides all the crucial company information required for business and competitor intelligence needs
• Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
• Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement

Reasons to Purchase

• Support sales activities by understanding your customers businesses better

*Qualify prospective partners and suppliers

• Keep fully up to date on your competitors business structure, strategy and prospects
• Obtain the most up to date company information available

This report covers the following industry codes:

SIC Code: 2834

NAICS Code: 325412